ExLibris header image
 

SFX by Ex Libris Inc.

Contains information about title and source of a journal
Naslov: EGFR Thr790Leu as a Potential Resistance Mechanism to First-Generation EGFR Tyrosine Kinase Inhibitor May Respond to Osimertinib in Patients With Lung Adenocarcinoma
Vir:

JTO Clinical and Research Reports [2666-3643] Cai, Xu-Wei l. 2021, letn. 2, št. 7, str. 100185 -100185

List of services to meet your request

Contains list of services for current record

Basic services

Celotno besedilo

service type icon, opens target in new window
Celotno besedilo dostopno v
Elsevier ScienceDirect Journals Complete
 
 
  Dostopnost: Oddaljen dostop za študente in zaposlene Univerze na Primorskem.

service type icon, opens target in new window
Celotno besedilo dostopno v
Elsevier ScienceDirect Journals Complete
 
 
  Dostopnost: Dostop je mogoč iz prostorov Univerze na Primorskem.

service type icon, opens target in new window
Celotno besedilo dostopno v
DOAJ_DIRECTORY_OPEN_ACCESS_JOURNALS
 
 

service type icon, opens target in new window
Celotno besedilo dostopno v
PubMed Central
 
 

service type icon, opens target in new window
Celotno besedilo dostopno v
ROAD: Directory of Open Access Scholarly Resources
 
 

Celotno besedilo

service type icon, opens target in new window
Celotno besedilo morda dostopno preko oznake
DOI


© 2024 SFX by Ex Libris Inc. | Piškotki
CrossRef Omogočeno